Adrenocorticotropic hormone and dehydroepiandrosterone sulfate levels of rheumatoid arthritis patients treated with glucocorticoids

References

• Stewart PM. The adrenal cortex: Williams textbook of endocrinol-ogy. 10th ed. Philadelphia: Saunders; 2003. p. 491–551.
   Google Scholar
• Mobbs CV, Hof PR. Dehydroepiandrosterone and aging. In: Mobbs CV, Hof PR, editors. Functional endocrinology of aging (interdisciplinary topics in gerontology, 29). Basel: Karger; 1998. p. 217–27.
   Google Scholar
• Haden ST, Glowacki J, Hurwitz S, Rosen C, LeBoff MS. Effects of age on serum dehydroepiandrosterone sulfate, IGF-I, and IL-6 levels in women. Calcif Tissue Int 2000;66: 414–8.
   Google Scholar
• Cormier C, Souberbielle JC, Kahan A. DHEA in bone and joint diseases. Joint Bone Spine 2001;68:588–94.
   PubMed Web of Science ®Google Scholar
• Kawano H, Yasue H, Kitagawa A, Hirai N, Yoshida T, Soejima H, et al. Dehydroepiandrosterone Supplementation improves endot-helial function and insulin sensitivity in men. J Clin Endocrinol Metab 2003;88(7):3190–5.
   PubMed Web of Science ®Google Scholar
• Deighton CM, Watson MJ, Walker DJ. Sex hormones in post-menopausal HLA-identical rheumatoid arthritis discordant sibling pairs. J Ftheumatol 1992;19:1663–7.
   Google Scholar
• Hall GM, Perry LA, Spector TD. Depressed levels of dehy-droepiandrosterone sulphate in postmenopausal women with rheumatoid arthritis but no relation with axial bone density. Ann Rheum Dis 1993;52:211–4.
   Google Scholar
• Kogure T, Fujinaga H, Nfizawa A, Shimada Y, Itoh T, Terasawa K. Serum DHEAS level dose not correlate with disease activity in postmenopausal patients with rheumatoid arthritis. Clin Ftheumatol 1998;10:245–52.
   Google Scholar
• Kanik KS, Chrousos GP, Schumacher HR, Crane ML, Yarboro CH, Wilder RL. Adrenocorticotropin, glucocorticoid, and andro-gen secretion in patients with new onset synovitis/rheumatoid arthritis: relations with indices of inflammation. J Clin Endocrinol Metab 2000;85:1461–6.
   PubMed Web of Science ®Google Scholar
• Sternberg EM, Chrousos GP, Wilder RL, Gold PW. The stress response and the regulation of inflammatory disease. Ann Intern Med 1992;117:854–66.
   PubMed Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–24.
   PubMed Web of Science ®Google Scholar
• Lane MA, Ingram DK, Ball SS, Roth GS. Dehydroepiandro-sterone sulfate: a biomarker of primate aging slowed by calorie restriction. J Clin Endrocrinol Metab 1997;82:2093–6.
   PubMed Web of Science ®Google Scholar
• Neeck G, Federlin K, Graef V, Rusch D, Schmidt KL. Adrenal secretion of cortisol in patients with rheumatoid arthritis. J. Ftheumatol 1990;17:24–9.
   Google Scholar
• Kuroki Y, Takabayashi C, Nishiyama K, Shimada T, Shiozawa S, Chihara K, et al. Adrenocorticotropic hormone response to hypoglycemic stress was preserved by a single bedtime 3-mg dose of prednisolone in patients with rheumatoid arthritis. Mod Ftheumatol 2004;14:291–5.
   PubMedGoogle Scholar
• Soya H. Stress response to exercise and its hypothalamic regula-tion: possible role of arginine-vasopressin. In: Nose H, Gisolfi CV, Imaizumi K, editors. Exercise, nutrition and environmental stress, Traverse City: Cooper Publishing; 2001. p. 21–37.
   Google Scholar
• Wilder RL, Sternberg EM. Neuroendocrine hormonal factors in rheumatoid arthritis and related conditions. Curr Opin Ftheumatol 1990;2:436–40.
   PubMedGoogle Scholar
• Bateman A, Singh A, Kral T, Solomon S. The immune-hypothalamic-pituitary-adrenal axis. Endocrine Rev 1989;10:92–112.
   PubMed Web of Science ®Google Scholar
• Busbridge NJ, Grossman AB. Stress and the single cytokine: interleukin modulation of the pituitary-adrenal axis. Mol Cell Endocrinol 1991;82:C209–14.
   Google Scholar
• Hall J, Morand EF, Medbak S, Zaman M, Perry L, Goulding NJ, et al. Abnormal hypothalamic-pituitary-adrenal axis function in rheumatoid arthritis. Arthritis Rheum 1994;37:1132–7.
   PubMedGoogle Scholar
• Nishikaze 0, Furuya E. Stress and anticortisols_17-ketosteroid sul-fate conjugate as a biomarker in tissue repair and recovery. J UOEH 1998;20(4):273–95.
   Google Scholar
• Nishikaza 0, Furuya E, Murakami K. Distortion of adaptation (wear and tear and repair and recovery)-17-KS-sulfates and illness susceptibility in humans. Health Tactics 21st Cent 1994;223–7.
   Google Scholar
• Nishikaza 0, Furuya E, Maezawa M. Distortion of adaptation (wear and tear and repair and recovery)-17-KS-sulfates and psychosocial stress in humans. Health Tactics 21st Cent 1994;335–40.
   Google Scholar
• Selye H. History of the stress concept. In: Goldberger L, Breznitz S, editors. Handbook of stress. 2nd ed. New York: Free Press; 1993. p. 7–17.
   Google Scholar
• Yukioka M, Komatsubara Y, Shichikawa K, Maeda A, Yukioka K, Furumitsu Y. Measurement of stress levels in RA patients using urinary steroid hormones. Clin Ftheumatol 2004;16:301–7.
   Google Scholar
• Parker L, Eugene J, Farber D, Lifrak E, Lai M, Juler G. Dissocia-tion of adrenal androgen and cortisol levels in acute stress. Horm Metab Res 1985;17:209–12.
   PubMedGoogle Scholar
• Omura M, Nishikawa T, Ezuka T, Kino T, Yoshida A, Saito H, et al. Studies on serum levels of androstenedione, dehydroepian-drosterone and dehydroepiandrosterone sulfate in ageing and in patients with adrenocortical disease. Clin Biochem 1992;645–7.
   Google Scholar
• Feher KG, Feher T, Meretey K. Interrelationship between the immunological and steroid hormone parameters in rheumatoid Arthritis. Exp Clin Endocrinol 1986;87:38–42.
   Google Scholar
• Mirone L, Altomonte L, D'agostino P, Zoli A, Barini A, Magaro M. A study of serum androgen and cortisol levels in female pa-tients with rheumatoid arthritis. Correlation with disease activity. Clin Ftheumatol 1996;15:15–9.
   Google Scholar
• Sambrook PN, Eisman JA, Champion GD, Pocock NA. Sex hor-mone status and osteoporosis in postmenopausal women with rheumatoid arthritis. Arthritis Rheum 1988;31:973–8.
   PubMedGoogle Scholar
• Greendale GA, Edelstein S, Barrett-Connor E. Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo study. J Bone Miner Res 1997;12:1833–43.
   Google Scholar
• Villareal DT, Holloszy JO, Kohrt WM. Effects of DHEA replace-ment on bone mineral density and body composition in elderly women and men. Clin Endocrinol 2000;53:561–8.
   Google Scholar
• Straub RH, Scholmerich J, Zietz B. Replacement therapy with DHEA plus corticosteroids in patients with chronic inflammatory diseases-substitutes of adrenal and sex hormones. Z Ftheumatol 2000;59:108–18.
   Google Scholar
• Gordon CM, Grace E, Emans SJ, Goodman E, Crawford MH, Leboff MS. Changes in bone turnover markers and menstrual func-tion after short-term oral DHEA in young women with anorexia nervosa. J Bone Miner Res 1999;14:136–45.
   PubMed Web of Science ®Google Scholar
• Nawata H, Soen S, Takayanagi R, Tanaka I, Takaoka K, Fukunaga M, et al. Guideline on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004). J Bone Miner Metab 2005;23: 105–9.
   PubMed Web of Science ®Google Scholar
• Michel BA, Bloch DA, Wolfe F., Fries JF. Fractures in rheumatoid arthritis: an evaluation of associated risk factors. J Ftheumatol 1993;20:1666–9.
   Google Scholar
• Van Staa TP, Leufkens HGM, Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 2002;13:777–87.
   PubMed Web of Science ®Google Scholar
• Yukioka M, Komatsubara Y, Furumitsu Y, Yukioka K, Morris SJ, Ochi T. Variations in ACTH and DHEA(S) levels of RA patients after steroid administration. Arthritis Rheum 2004;50: 342.
   Google Scholar